Home/Filings/4/0001140361-18-043653
4//SEC Filing

Maxwell John T. 4

Accession 0001140361-18-043653

CIK 0001398733other

Filed

Nov 25, 7:00 PM ET

Accepted

Nov 26, 1:39 PM ET

Size

4.3 KB

Accession

0001140361-18-043653

Insider Transaction Report

Form 4
Period: 2018-11-21
Maxwell John T.
SVP-Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2018-11-21$9.80/sh+10,000$98,000148,614 total
Footnotes (1)
  • [F1]Includes 10,000 shares owned jointly with Mr. Maxwell's spouse.

Issuer

Aquestive Therapeutics, Inc.

CIK 0001398733

Entity typeother

Related Parties

1
  • filerCIK 0001739025

Filing Metadata

Form type
4
Filed
Nov 25, 7:00 PM ET
Accepted
Nov 26, 1:39 PM ET
Size
4.3 KB